EPHA4 and pancreatic neoplasm: The results demonstrated cytostatic efficacy in PDAC cells expressing EphA4, both in vitro and in orthotopic pancreatic cancer models, by suppressing the phosphorylation of EphA4 and Akt, and inducing apoptosis.